U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H16N4O3.2Cl.H2O
Molecular Weight 377.223
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ASOXIME CHLORIDE MONOHYDRATE

SMILES

O.[Cl-].[Cl-].NC(=O)C1=CC=[N+](COC[N+]2=CC=CC=C2\C=N\O)C=C1

InChI

InChIKey=GYEZCRHNOKYBFX-UHFFFAOYSA-N
InChI=1S/C14H14N4O3.2ClH.H2O/c15-14(19)12-4-7-17(8-5-12)10-21-11-18-6-2-1-3-13(18)9-16-20;;;/h1-9H,10-11H2,(H-,15,19);2*1H;1H2

HIDE SMILES / InChI

Molecular Formula C14H15N4O3
Molecular Weight 287.2939
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Molecular Formula HO
Molecular Weight 17.0073
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
667.8 µM [IC50]
PubMed

PubMed

TitleDatePubMed
Spontaneous and oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates.
1988
Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds.
1996
Comparison of oxime-initiated reactivation of organophosphorous-inhibited acetylcholinesterase in brains of avian embryos.
2000 Jan 14
Active site mutant acetylcholinesterase interactions with 2-PAM, HI-6, and DDVP.
2006 Apr 14
Improvement of acetylcholinesterase-based assay for organophosphates in way of identification by reactivators.
2008 Oct 19
Comparison of oxime reactivation and aging of nerve agent-inhibited monkey and human acetylcholinesterases.
2008 Sep 25
A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.
2008 Sep 25
New bispyridinium oximes: in vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning.
2008 Sep 25
Comparison of the oxime-induced reactivation of rhesus monkey, swine and guinea pig erythrocyte acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
2009 Apr 28
Effect of acetylcholinesterase oxime-type reactivators K-48 and HI-6 on human liver microsomal cytochromes P450 in vitro.
2009 Aug 14
In vitro reactivation of trichlorfon-inhibited butyrylcholinesterase using HI-6, obidoxime, pralidoxime and K048.
2009 Jun
Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
2009 Jun 1
Comparative study of oxime-induced reactivation of erythrocyte and muscle AChE from different animal species following inhibition by sarin or paraoxon.
2010 May 4
Prediction of soman-induced cerebral damage by distortion product otoacoustic emissions.
2010 Nov 9
Comparison of human and guinea pig acetylcholinesterase sequences and rates of oxime-assisted reactivation.
2010 Sep 6
Interactions of pyridinium oximes with acetylcholinesterase.
2010 Sep 6
Interaction kinetics of oximes with native, phosphylated and aged human acetylcholinesterase.
2010 Sep 6
In vivo reactivation by oximes of inhibited blood, brain and peripheral tissue cholinesterase activity following exposure to nerve agents in guinea pigs.
2010 Sep 6
Tabun-inhibited rat tissue and blood cholinesterases and their reactivation with the combination of trimedoxime and HI-6 in vivo.
2010 Sep 6
Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
2010 Sep 6
Mechanism for potent reactivation ability of H oximes analyzed by reactivation kinetic studies with cholinesterases from different species.
2010 Sep 6
In vitro ability of currently available oximes to reactivate organophosphate pesticide-inhibited human acetylcholinesterase and butyrylcholinesterase.
2011
Gene expression and phosphoprotein profile of certain key neuronal signaling proteins following soman intoxication.
2011 Dec 18
Kinetic analysis of interactions of paraoxon and oximes with human, Rhesus monkey, swine, rabbit, rat and guinea pig acetylcholinesterase.
2011 Jan 15
Effect of different buffers on kinetic properties of human acetylcholinesterase and the interaction with organophosphates and oximes.
2011 Mar
In vitro effects of acetylcholinesterase reactivators on monoamine oxidase activity.
2011 Mar 5
Amidine-oximes: reactivators for organophosphate exposure.
2011 May 12
Reactivation of organophosphate-inhibited human acetylcholinesterase by isonitrosoacetone (MINA): a kinetic analysis.
2011 Nov 15
A comparison of the reactivating and therapeutic efficacy of chosen combinations of oximes with individual oximes against VX in rats and mice.
2011 Oct
Restoration of nerve agent inhibited muscle force production in human intercostal muscle strips with HI 6.
2011 Sep 25
Immobilization of Russian VX skin depots by localized cooling: implications for decontamination and medical countermeasures.
2011 Sep 25
Increasing oxime efficacy by blood-brain barrier modulation.
2011 Sep 25
Comparative kinetics of organophosphates and oximes with erythrocyte, muscle and brain acetylcholinesterase.
2012 Mar 7
Two medical therapies very effective shortly after high levels of soman poisoning in rats, but only one with universal utility.
2013 Dec 15
In vitro investigation of efficacy of new reactivators on OPC inhibited rat brain acetylcholinesterase.
2013 Mar 25
Syntheses and in vitro evaluations of uncharged reactivators for human acetylcholinesterase inhibited by organophosphorus nerve agents.
2013 Mar 25
A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
2013 Mar 25
Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning.
2013 Mar 25
Reactions of methylphosphonic difluoride with human acetylcholinesterase and oximes--Possible therapeutic implications.
2014 Nov 18
Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
2015 Feb 3
Probing the role of amino acids in oxime-mediated reactivation of nerve agent-inhibited human acetylcholinesterase.
2015 Mar
Pharmacokinetic profile and quantitation of protection against soman poisoning by the antinicotinic compound MB327 in the guinea-pig.
2016 Feb 26
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:16:38 UTC 2023
Edited
by admin
on Sat Dec 16 08:16:38 UTC 2023
Record UNII
FE358MQ67Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ASOXIME CHLORIDE MONOHYDRATE
MI  
Common Name English
PYRIDINIUM, 1-(((4-(AMINOCARBONYL)PYRIDINIO)METHOXY)METHYL)-2-((HYDROXYIMINO)METHYL)-, CHLORIDE, HYDRATE (1:2:1)
Systematic Name English
ASOXIME CHLORIDE MONOHYDRATE [MI]
Common Name English
PYRIDINIUM, 1-(((4-(AMINOCARBONYL)PYRIDINIO)METHOXY)METHYL)-2-((HYDROXYIMINO)METHYL)-, DICHLORIDE, MONOHYDRATE
Systematic Name English
Code System Code Type Description
FDA UNII
FE358MQ67Y
Created by admin on Sat Dec 16 08:16:38 UTC 2023 , Edited by admin on Sat Dec 16 08:16:38 UTC 2023
PRIMARY
MERCK INDEX
m2095
Created by admin on Sat Dec 16 08:16:38 UTC 2023 , Edited by admin on Sat Dec 16 08:16:38 UTC 2023
PRIMARY Merck Index
CAS
82504-20-9
Created by admin on Sat Dec 16 08:16:38 UTC 2023 , Edited by admin on Sat Dec 16 08:16:38 UTC 2023
PRIMARY
PUBCHEM
135565615
Created by admin on Sat Dec 16 08:16:38 UTC 2023 , Edited by admin on Sat Dec 16 08:16:38 UTC 2023
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE